Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $62 to $78.
Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $62 to $78.